W. L. GORE & ASSOCIATES, INC. GORE® EXCLUDER®AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
|
Back to Search Results |
|
Catalog Number PLA280300J |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problem
Obstruction/Occlusion (2422)
|
Event Date 04/09/2024 |
Event Type
Injury
|
Manufacturer Narrative
|
H3: code "other" was selected as the medical device remains implanted.Return not possible.H6: a review of the manufacturing records for the device verified that the lot met all pre-release specifications.According to the gore® excluder®aaa endoprosthesis instructions for use (ifu), adverse events that may occur and/or require intervention or additional intraoperative procedure time include, but are not limited to: occlusion of device or native vessel.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
|
Event Description
|
On (b)(6) 2024, this patient underwent an endovascular treatment of an abdominal aortic aneurysm using gore® excluder® conformable aaa endoprosthesis and gore® excluder® aaa endoprosthesis.Reportedly, an aortic extender component was intentionally deployed in a position that partially covered the right renal artery.The final angiography revealed that blood flow in the right renal artery.The patient tolerated the procedure.On (b)(6) 2024, the right renal artery occlusion was confirmed on the echography.Reportedly, a percutaneous transluminal renal angioplasty(ptra) via the brachial or thoracic arteries was considered, but was abandoned due to the poor condition of the thoracic vessels.The physician reported that since the patient had about one year to live due to lung cancer, the priority was given to treating the proximal type i endoleak rather than protecting the renal artery.
|
|
Search Alerts/Recalls
|
|
|